06Jun
Supreme Court Decides Prescription Drug Preemption Case in Favor of Drug Manufacturer
The United States Supreme Court finally clarified its 11-year-old “clear evidence” standard for pharmaceutical preemption. In its much-anticipated opinion delivered by Justice Breyer, the Court unanimously reversed the Third Circuit’s holding that...
By:
Morrison & Foerster LLP - Class Dismissed
Related
A local air district is developing a rule that would require both existing and proposed warehouses t...
Read More >
Since 2016, hundreds of bills and dozens of new laws aimed at closing the pay gap have been introduc...
Read More >
On October 22, 2019, the Department of Labor (DOL) issued proposed regulations providing guidance fo...
Read More >
Private equity-backed takeovers of listed companies in Western Europe have enjoyed several strong ye...
Read More >
Waiting on Dorian to arrive or to skip Florida altogether got me thinking about the HR challenges of...
Read More >
Opioid manufacturer Insys Therapeutics, which just last week agreed to pay $225 million to “settle ...
Read More >